507 related articles for article (PubMed ID: 18177451)
1. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
4. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
5. Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy.
Ng FH; Lam KF; Wong SY; Chang CM; Lau YK; Yuen WC; Chu WM; Wong BC
Digestion; 2008; 77(3-4):173-7. PubMed ID: 18577887
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
Jiang Z; Wu H; Duan Z; Wang Z; Hu K; Ye F; Zhang Z
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Schreiner GC; Laine L; Murphy SA; Cannon CP
Crit Pathw Cardiol; 2007 Dec; 6(4):169-72. PubMed ID: 18091407
[TBL] [Abstract][Full Text] [Related]
8. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
[TBL] [Abstract][Full Text] [Related]
10. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
11. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
Buresly K; Eisenberg MJ; Zhang X; Pilote L
Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
[TBL] [Abstract][Full Text] [Related]
12. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
13. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
Liberopoulos EN; Elisaf MS; Tselepis AD; Archimandritis A; Kiskinis D; Cokkinos D; Mikhailidis DP
Platelets; 2006 Feb; 17(1):1-6. PubMed ID: 16308180
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
Denardo SJ; Davis KE; Tcheng JE
Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
[TBL] [Abstract][Full Text] [Related]
16. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Ng FH; Tunggal P; Chu WM; Lam KF; Li A; Chan K; Lau YK; Kng C; Keung KK; Kwan A; Wong BC
Am J Gastroenterol; 2012 Mar; 107(3):389-96. PubMed ID: 22108447
[TBL] [Abstract][Full Text] [Related]
17. Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel.
Caruana JA; McCabe MN; Smith AD; Panemanglore VP; Sette Camara D
Surg Obes Relat Dis; 2007; 3(4):443-5. PubMed ID: 17400519
[TBL] [Abstract][Full Text] [Related]
18. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Delaney JA; Opatrny L; Brophy JM; Suissa S
CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
[TBL] [Abstract][Full Text] [Related]
19. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.
Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R
N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862
[TBL] [Abstract][Full Text] [Related]
20. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]